Search

Pulse Biosciences Inc

Fermé

SecteurSoins de santé

49.12 -2.5

Résumé

Variation du prix de l'action

24h

Actuel

Min

48.92

Max

50.38

Chiffres clés

By Trading Economics

Revenu

-6.1M

-25M

Ventes

33K

434K

BPA

-0.36

Marge bénéficiaire

-5,681.336

Employés

116

EBITDA

-5.8M

-25M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

-10.25% downside

Dividendes

By Acuity

Prochains Résultats

4 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

726M

3.3B

Ouverture précédente

51.62

Clôture précédente

49.12

Sentiment de l'Actualité

By Acuity

61%

39%

299 / 340 Classement par Healthcare

Pulse Biosciences Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 août 2026, 23:36 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a brief peak, amid broader market concerns over geopolitical tensions affecting oil supply.

20 août 2026, 20:06 UTC

Pulse Biosciences Inc is higher in Thursday's session, reflecting a broader market trend. The stock is trading above its 20-day moving average.

19 août 2026, 19:16 UTC

Pulse Biosciences Inc is trading higher, maintaining gains since Tuesday's close. The stock remains above its 20-day moving average and near its one-month range high.

18 août 2026, 19:56 UTC

News

Pulse Biosciences announced inducement grants for new employees, raising potential dilution concerns. Shares are trading lower during Tuesday's session, retracing from an early peak.

17 août 2026, 22:36 UTC

Pulse Biosciences Inc shares are trading higher in after-market hours. The stock has gained significantly over the past month, reflecting broader market dynamics.

14 août 2026, 19:11 UTC

Pulse Biosciences Inc shares are declining, breaking a trend of higher closes. The broader market reacts to an unexpected decline in U.S. retail sales.

13 août 2026, 20:06 UTC

Pulse Biosciences Inc shares are higher, maintaining gains since Wednesday's close despite earlier intraday volatility and no specific news driving the movement.

12 août 2026, 20:06 UTC

Pulse Biosciences Inc. shares are lower today, continuing a decline after an early peak. The asset remains above its 20-day moving average.

11 août 2026, 23:01 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reversing earlier gains despite being above its 20-day moving average. No specific news was identified.

10 août 2026, 21:01 UTC

Pulse Biosciences Inc shares are lower in after-market hours, reflecting no specific news to explain the movement. The asset remains above its 20-day moving average.

7 août 2026, 19:51 UTC

News

Pulse Biosciences shares are higher after reporting second-quarter revenue of $434,000 and increasing patient enrollment targets for its pivotal trial.

6 août 2026, 22:16 UTC

News

Pulse Biosciences reported a net loss of $24.7 million for Q2 2026. Shares are trading higher after announcing significant progress in its cardiac catheter program.

5 août 2026, 20:06 UTC

Pulse Biosciences Inc shares are lower during Wednesday's trading session, reversing from a recent trend of higher daily closes. No specific news was identified.

3 août 2026, 20:03 UTC

Pulse Biosciences Inc shares are higher today, driven by a significant advance in the Health Care Equipment sector and unusually high trading volume.

31 juil. 2026, 19:16 UTC

Pulse Biosciences Inc is gaining during Friday's session, reaching a high above Thursday's close. The stock remains above its 20-day moving average.

30 juil. 2026, 20:09 UTC

Event

Pulse Biosciences' NANOPULSE-AF Study enrollment surpasses midpoint, supporting stock gains since Wednesday. Shares remain above the 20-day moving average amid market volatility.

29 juil. 2026, 22:03 UTC

Event

Pulse Biosciences shares are lower in after-market hours despite surpassing enrollment midpoint in its NANOPULSE-AF Study, reflecting broader cautious market sentiment.

28 juil. 2026, 23:46 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reflecting volatility amid broader market declines, though no specific news was identified.

27 juil. 2026, 19:51 UTC

Pulse Biosciences Inc shares are higher today amid unusually high trading volume, despite earlier downward movement. No specific news was identified to explain the move.

24 juil. 2026, 18:11 UTC

Pulse Biosciences Inc shares are lower today, breaking a trend of higher daily closes. The stock is trading with unusually high market volume.

22 juil. 2026, 19:31 UTC

Pulse Biosciences shares are higher today amid increased trading volume, despite earlier pulling back from session highs. No specific news was identified to explain the movement.

21 juil. 2026, 22:51 UTC

Pulse Biosciences Inc shares declined in after-market trading, reversing earlier gains. No specific news was identified to explain the price movement.

20 juil. 2026, 19:26 UTC

Shares of Pulse Biosciences Inc. are lower today, reversing earlier gains amid broader market pressure from rising US Treasury yields and geopolitical uncertainties.

Comparaison

Variation de prix

Pulse Biosciences Inc prévision

Objectif de Prix

By TipRanks

-10.25% baisse

Prévisions sur 12 Mois

Moyen 45.25 USD  -10.25%

Haut 58 USD

Bas 35 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

4 ratings

4

Achat

0

Maintien

0

Vente

Sentiment

By Acuity

299 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat